CPT code 0253U: Receptivity profile, 238-gene RNA analysis2026 Medicare lab fee · Clinical Laboratory Fee Schedule
This reproductive medicine assay profiles RNA expression in endometrial tissue to predict whether the uterine lining is pre-receptive, receptive, or post-receptive.
Medicare pays $3,159.42 for 0253U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$3,159.42
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 0253U covers
This proprietary reproductive medicine assay analyzes RNA expression across 238 genes in endometrial tissue using next-generation sequencing. A predictive algorithm reports the endometrial window of implantation as pre-receptive, receptive, or post-receptive. Fertility specialists may order it during IVF care when assessing whether embryo-transfer timing should be guided by the patient’s endometrial receptivity. The tissue is obtained by endometrial biopsy and sent to a laboratory performing the assay.
Report 0253U for the completed gene-expression profile; it is a laboratory service rather than a physician interpretation service. Medicare pays it only through the CLFS, with one national amount per code and no locality or office-versus-facility adjustment. The 2026 national CLFS amount is $3,159.42, unchanged from 2023 through 2025. Medicare makes no separate physician fee schedule payment for this code.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0253U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0253U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0253U: Medicare pays the test only from the CLFS.
0253U on the lab fee schedule since 2021
0253U · CLFS 2026 Q4 (current)
$3,159.42
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $3,159.42
22 quarterly CLFS releases on file, first CLFS 2021 Q3. A code missing from a quarter wasn’t on that release.
0253U compared with similar tests
- 0254UEmbryo genetics24 chromosomes, per embryo$759.05
- 0254U is a reproductive medicine chromosome-analysis assay. Choose 0253U when the service is the 238-gene endometrial RNA profile predicting receptivity.
- 0255USperm function testGM1 fluorescence microscopy$31.60
- 0255U is an andrology infertility assessment. It addresses male-factor evaluation, unlike 0253U’s endometrial tissue RNA profile.
0253U billing questions
What specimen is tested?
The assay uses endometrial tissue obtained by biopsy. The reported result predicts the endometrial window of implantation.
What does the result report?
A predictive algorithm categorizes the endometrial window as pre-receptive, receptive, or post-receptive.
How does 0253U differ from 0254U?
0253U evaluates endometrial RNA expression to predict receptivity. 0254U is a separate reproductive medicine assay involving chromosome analysis.
Is a physician interpretation separately payable?
No separate physician fee schedule payment is made for 0253U. Medicare pays the code through the CLFS.
Does Medicare use a local rate for this code?
No. Medicare uses one national CLFS amount for the code across localities, without an office-versus-facility adjustment.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0253U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist